Posts - Bill - S 2710 Open Payments Expansion Act
senate 09/04/2025 - 119th Congress
We want to ensure transparency by requiring drug and device makers to publicly disclose any payments they make to patient advocacy groups, so everyone can see how these organizations are funded.
Congress.gov
S 2710 - Open Payments Expansion Act
Views
left-leaning 09/04/2025
Patient advocates should fight for patients, not profit margins; this bill keeps the profiteers honest.
left-leaning 09/04/2025
Finally, a little sunshine on pharma’s secret handshakes with patient groups—transparency isn’t just a buzzword.
moderate 09/04/2025
If you’re taking money from Big Pharma, the public deserves to know who’s cashing checks and why.
moderate 09/04/2025
Transparency isn’t left or right; it’s just common sense in a democracy that trusts its watchdogs.
right-leaning 09/04/2025
Patient groups should speak for patients, not make pharma’s party expenses public news.
left-leaning 09/04/2025
Expose the money trail or stay part of the problem—this bill demands truth, not hush money.
right-leaning 09/04/2025
Sunlight’s great unless it blurs the lines between private charity and public shaming.
moderate 09/04/2025
Disclosure bills remind us all to beware of backdoor deals dressed as goodwill.
right-leaning 09/04/2025
Another layer of red tape—because nothing says healthcare freedom like government peeking over your shoulder.